Carley; David W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Carley; David W..The latest application filed is for "methods for treating sleep disorders by cholecystokinin (cck) receptor b antagonists".

Company Profile

0.11.15

Carley; David W. - Chicago IL
Carley; David W. - Evanston IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Detection and prediction of physiological events in people with sleep disordered breathing using a LAMSTAR neural network Grant 8,775,340 - Waxman , et al. July 8, 2	2014-07-08
Methods For Treating Sleep Disorders By Cholecystokinin (cck) Receptor B Antagonists App 20140045755 - Carley; David W. ; et al.	2014-02-13
Functional role for cannabinoids in autonomic stability during sleep Grant 8,207,230 - Carley , et al. June 26, 2	2012-06-26
Pharmacological Treatment for Sleep Apnea App 20120108570 - Radulovacki; Miodrag ; et al.	2012-05-03
Methods for Treating Sleep Disorders by Cholecystokinin (CCK) Receptor B Antagonists App 20120010198 - Carley; David W. ; et al.	2012-01-12
Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists Grant 8,076,315 - Carley , et al. December 13, 2	2011-12-13
Methods for treating sleep disorders by cholecystokinin (CCK) receptor B antagonists Grant 8,053,413 - Carley , et al. November 8, 2	2011-11-08
Detection and Prediction of Physiological Events in People with Sleep Disordered Breathing Using a LAMSTAR Neural Network App 20110251985 - Waxman; Jonathan ; et al.	2011-10-13
Functional Role for Cannabinoids in Autonomic Stability During Sleep App 20100137251 - Carley; David W. ; et al.	2010-06-03
Method for treating sleep apnea Grant 7,705,039 - Carley , et al. April 27, 2	2010-04-27
Pharmacological Treatment for Sleep Apnea App 20090221658 - Radulovacki; Miodrag ; et al.	2009-09-03
Pharmacological Treatment for Sleep Apnea App 20090005357 - Radulovacki; Miodrag ; et al.	2009-01-01
Pharmacological Treatments for Sleep Disorders (Apnoe) With Prostanoid Receptor Antagonists App 20080261922 - Carley; David W. ; et al.	2008-10-23
Compositions and Methods for Treating Sleep Disorders App 20080200367 - Carley; David W. ; et al.	2008-08-21
Pharmacological treatment for sleep apnea App 20070123517 - Radulovacki; Miodrag ; et al.	2007-05-31
Pharmacological treatment for sleep apnea Grant 7,160,898 - Radulovacki , et al. January 9, 2	2007-01-09
Pharmacological treatment for sleep apnea App 20060241164 - Radulovacki; Miodrag ; et al.	2006-10-26
Neuropharmacological treatment of sleep-related breathing disorders Grant 6,974,814 - Radulovacki , et al. December 13, 2	2005-12-13
Functional role for cannabinoids in autonomic stability during sleep App 20040127572 - Carley, David W. ; et al.	2004-07-01
Pharmacological treatment for sleep apnea Grant 6,727,242 - Radulovacki , et al. April 27, 2	2004-04-27
Neuropharmacological treatment of sleep-related breathing disorders App 20030236228 - Radulovacki, Miodrag ; et al.	2003-12-25
Pharmacological treatment for sleep apnea App 20030130266 - Radulovacki, Miodrag ; et al.	2003-07-10
Neuropharmacological treatments of sleep-related breathing disorders Grant 6,555,564 - Radulovacki , et al. April 29, 2	2003-04-29
Pharmacological treatment for sleep apnea App 20020086870 - Radulovacki, Miodrag ; et al.	2002-07-04
Pharmacological treatment for sleep apnea Grant 6,331,536 - Radulovacki , et al. December 18, 2	2001-12-18

Company Registrations

NCAGE Code	4RK49	CARLEY, DAVID W
CAGE Code	4RK49	CARLEY, DAVID W
SEC	0001556271	Carley David W.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.